A comprehensive view of Haystack Oncology. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Quest Diagnostics completes acquisition of Haystack Oncology, adding MRD liquid biopsy technology to cancer diagnostics portfolio; Quest to use the technology to develop new blood-based clinical lab services for solid tumor cancers available in 2024 
Published: June 21, 2023 by Quest Diagnostics Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count